JP2022526285A - 光照射装置 - Google Patents
光照射装置 Download PDFInfo
- Publication number
- JP2022526285A JP2022526285A JP2021556330A JP2021556330A JP2022526285A JP 2022526285 A JP2022526285 A JP 2022526285A JP 2021556330 A JP2021556330 A JP 2021556330A JP 2021556330 A JP2021556330 A JP 2021556330A JP 2022526285 A JP2022526285 A JP 2022526285A
- Authority
- JP
- Japan
- Prior art keywords
- light
- irradiation device
- irradiated
- skin
- time
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000758 substrate Substances 0.000 claims abstract description 32
- 230000035515 penetration Effects 0.000 claims abstract description 31
- 230000001678 irradiating effect Effects 0.000 claims abstract description 17
- 238000010586 diagram Methods 0.000 abstract description 9
- 210000003491 skin Anatomy 0.000 description 59
- 206010052428 Wound Diseases 0.000 description 54
- 208000027418 Wounds and injury Diseases 0.000 description 54
- 244000052769 pathogen Species 0.000 description 32
- 241000894006 Bacteria Species 0.000 description 28
- 230000001717 pathogenic effect Effects 0.000 description 24
- 210000004207 dermis Anatomy 0.000 description 22
- 210000002615 epidermis Anatomy 0.000 description 21
- 238000000034 method Methods 0.000 description 17
- 230000001954 sterilising effect Effects 0.000 description 15
- 230000000694 effects Effects 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 10
- 230000029663 wound healing Effects 0.000 description 10
- 238000004659 sterilization and disinfection Methods 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 8
- 210000004204 blood vessel Anatomy 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 230000035876 healing Effects 0.000 description 8
- 239000003642 reactive oxygen metabolite Substances 0.000 description 8
- 238000011084 recovery Methods 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 210000000987 immune system Anatomy 0.000 description 5
- 230000009471 action Effects 0.000 description 4
- 210000002865 immune cell Anatomy 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 230000010534 mechanism of action Effects 0.000 description 4
- 108090000695 Cytokines Proteins 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000036560 skin regeneration Effects 0.000 description 3
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 229960001456 adenosine triphosphate Drugs 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 150000004032 porphyrins Chemical class 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 230000009946 DNA mutation Effects 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000035901 Ischaemic ulcer Diseases 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000037456 inflammatory mechanism Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002955 secretory cell Anatomy 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0616—Skin treatment other than tanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0624—Apparatus adapted for a specific treatment for eliminating microbes, germs, bacteria on or in the body
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
- H05B47/00—Circuit arrangements for operating light sources in general, i.e. where the type of light source is not relevant
- H05B47/10—Controlling the light source
- H05B47/155—Coordinated control of two or more light sources
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
- H05B47/00—Circuit arrangements for operating light sources in general, i.e. where the type of light source is not relevant
- H05B47/10—Controlling the light source
- H05B47/16—Controlling the light source by timing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
- A61N2005/0629—Sequential activation of light sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0642—Irradiating part of the body at a certain distance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
- A61N2005/0663—Coloured light
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02B—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO BUILDINGS, e.g. HOUSING, HOUSE APPLIANCES OR RELATED END-USER APPLICATIONS
- Y02B20/00—Energy efficient lighting technologies, e.g. halogen lamps or gas discharge lamps
- Y02B20/40—Control techniques providing energy savings, e.g. smart controller or presence detection
Abstract
Description
Claims (20)
- 傷を負った皮膚に光を照射する光源部と、
前記光源部を制御する制御部と、を含み、
前記光源部は、
基板と、
前記基板上に設けられ、青色波長帯域の第1の光を照射する少なくとも1つの第1の光源と、
前記基板上に設けられ、赤色乃至近赤外線波長帯域の第2の光を照射する少なくとも1つの第2の光源と、を含み、
前記第1の光及び前記第2の光は、波長に応じて互いに異なる皮膚侵入深さを有し、前記第1の光の皮膚侵入深さと前記第2の光の皮膚侵入深さとの差は約1.8mm以上である光照射装置。 - 前記第1の光は、約1.0mm以上の皮膚侵入深さを有する、請求項1に記載の光照射装置。
- 前記第2の光は、約4.3mm以上の皮膚侵入深さを有する、請求項2に記載の光照射装置。
- 前記第1の光は、約370nm~約500nmの波長帯域の光である、請求項1に記載の光照射装置。
- 前記第1の光は、約385nm~約435nmの波長帯域の光である、請求項4に記載の光照射装置。
- 前記第2の光は、約610nm~約940nmの波長帯域の光である、請求項4に記載の光照射装置。
- 前記第1の光と第2の光は、所定の時間、同時に照射される、請求項1に記載の光照射装置。
- 前記第1の光は第1の時間照射され、前記第2の光は、前記第1の時間より長い第2の時間照射される、請求項1に記載の光照射装置。
- 前記第2の光は、前記第1の光の照射が終了する前に照射が開始され、前記第1の時間と前記第2の時間の少なくとも一部は、互いに重畳する期間を有する、請求項8に記載の光照射装置。
- 前記第2の光は連続的に照射される、請求項9に記載の光照射装置。
- 前記第1の光は不連続的に照射される、請求項7に記載の光照射装置。
- 前記第1の光及び前記第2の光のうち少なくとも一方は周期的に照射される、請求項7に記載の光照射装置。
- 前記光照射装置は治療用である、請求項1に記載の光照射装置。
- 前記第1の光の前記皮膚への照射範囲は、前記第2の光の前記皮膚への照射範囲より小さい、請求項1に記載の光照射装置。
- 前記基板は、前記皮膚と対向し、前記第1の光源が設けられた第1の領域と、前記第2の光源が設けられた第2の領域と、を含み、前記第2の領域は前記第1の領域を囲む、請求項14に記載の光照射装置。
- 前記第1の領域に対応する面は、前記第2の領域に対応する面より前記皮膚から遠くなるように設けられている、請求項15に記載の光照射装置。
- 青色波長帯域の第1の光を照射する少なくとも1つの第1の光源と、
赤色乃至近赤外線波長帯域の第2の光を照射する少なくとも1つの第2の光源と、
前記第1及び第2の光源を制御する制御部と、を含み、
前記第1の光及び前記第2の光は、波長に応じて互いに異なる皮膚侵入深さを有し、前記第1の光の皮膚侵入深さと前記第2の光の皮膚侵入深さとの差は約1.8mm以上である光照射装置。 - 前記第1の光は約0.8mm以上の皮膚侵入深さを有し、前記第2の光は約4.3mm以上の皮膚侵入深さを有する、請求項17に記載の光照射装置。
- 前記第1の光は、約370nm~約500nmの波長帯域の光である、請求項18に記載の光照射装置。
- 前記第1の光は第1の時間照射され、前記第2の光は、前記第1の時間より長い第2の時間照射される、請求項17に記載の光照射装置。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962820493P | 2019-03-19 | 2019-03-19 | |
US62/820,493 | 2019-03-19 | ||
US16/821,024 US20200298016A1 (en) | 2019-03-19 | 2020-03-17 | Light irradiation device |
US16/821,024 | 2020-03-17 | ||
PCT/KR2020/003692 WO2020190022A1 (ko) | 2019-03-19 | 2020-03-18 | 광 조사 장치 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2022526285A true JP2022526285A (ja) | 2022-05-24 |
JPWO2020190022A5 JPWO2020190022A5 (ja) | 2023-03-28 |
JP7472162B2 JP7472162B2 (ja) | 2024-04-22 |
Family
ID=72514088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021556330A Active JP7472162B2 (ja) | 2019-03-19 | 2020-03-18 | 光照射装置 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20200298016A1 (ja) |
EP (1) | EP3943151A4 (ja) |
JP (1) | JP7472162B2 (ja) |
KR (1) | KR20210129711A (ja) |
WO (1) | WO2020190022A1 (ja) |
ZA (3) | ZA202106885B (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210128935A1 (en) * | 2015-07-28 | 2021-05-06 | Know Bio, Llc | Phototherapeutic light for treatment of pathogens |
CN111701144B (zh) | 2015-07-28 | 2023-03-21 | 诺欧生物有限责任公司 | 用于对一氧化氮的光疗调节的系统和方法 |
US11147984B2 (en) | 2020-03-19 | 2021-10-19 | Know Bio, Llc | Illumination devices for inducing biological effects |
EP4244541A1 (en) * | 2020-11-10 | 2023-09-20 | Signify Holding B.V. | Render of disinfectant light with ir and uv components |
US11654294B2 (en) | 2021-03-15 | 2023-05-23 | Know Bio, Llc | Intranasal illumination devices |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040122492A1 (en) * | 1999-07-07 | 2004-06-24 | Yoram Harth | Phototherapeutic treatment of skin conditions |
US20090177253A1 (en) | 2008-01-08 | 2009-07-09 | Oregon Aesthetic Technologies | Skin therapy system |
KR101138717B1 (ko) * | 2009-11-17 | 2012-04-24 | 재단법인 철원플라즈마 산업기술연구원 | 피부 진단 및 치료 장치와 이를 이용한 피부 진단 및 치료 방법 |
EP2383017A1 (en) * | 2010-04-28 | 2011-11-02 | Koninklijke Philips Electronics N.V. | Phototherapy device |
KR20120069588A (ko) * | 2010-12-20 | 2012-06-28 | 주식회사 루트로닉 | 광 치료장치 및 이의 제어방법 |
US9950190B2 (en) * | 2011-07-03 | 2018-04-24 | Medical Quant Ltd | Device and method of treating fungal nail infections |
US8900283B2 (en) * | 2011-11-08 | 2014-12-02 | Biophotas, Inc. | Shapeable light therapy and method |
JP2016511672A (ja) | 2013-03-01 | 2016-04-21 | クロックス テクノロジーズ インコーポレイテッドKlox Technologies Inc. | 光線療法装置、方法および使用 |
KR101598665B1 (ko) * | 2013-09-23 | 2016-02-29 | 박행배 | 피부개선 및 발모용 광 요법 장치 |
US20160016001A1 (en) * | 2014-02-28 | 2016-01-21 | Klox Technologies Inc. | Phototherapeutic device, method and use |
KR101561448B1 (ko) * | 2014-06-05 | 2015-10-30 | 동방국제지주 주식회사 | 미립자를 포함하는 도광판을 이용한 광치료기 |
US10765885B2 (en) * | 2016-02-26 | 2020-09-08 | Nanoco Technologies Ltd. | Phototherapy mask with quantum dot phosphors |
US11185279B2 (en) * | 2017-01-18 | 2021-11-30 | Koninklijke Philips N.V. | Detecting erythema caused by wearable devices |
-
2020
- 2020-03-17 US US16/821,024 patent/US20200298016A1/en active Pending
- 2020-03-18 EP EP20773884.0A patent/EP3943151A4/en active Pending
- 2020-03-18 JP JP2021556330A patent/JP7472162B2/ja active Active
- 2020-03-18 WO PCT/KR2020/003692 patent/WO2020190022A1/ko unknown
- 2020-03-18 KR KR1020217031097A patent/KR20210129711A/ko unknown
-
2021
- 2021-09-17 ZA ZA2021/06885A patent/ZA202106885B/en unknown
-
2022
- 2022-12-07 ZA ZA2022/13282A patent/ZA202213282B/en unknown
-
2023
- 2023-04-26 ZA ZA2023/04878A patent/ZA202304878B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2020190022A1 (ko) | 2020-09-24 |
ZA202304878B (en) | 2024-03-27 |
EP3943151A1 (en) | 2022-01-26 |
ZA202213282B (en) | 2023-04-26 |
JP7472162B2 (ja) | 2024-04-22 |
ZA202106885B (en) | 2023-02-22 |
KR20210129711A (ko) | 2021-10-28 |
EP3943151A4 (en) | 2022-12-07 |
US20200298016A1 (en) | 2020-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2022526285A (ja) | 光照射装置 | |
US20220176147A1 (en) | Wearable Micro-LED Healing Bandage | |
Beckmann et al. | Low level laser therapy for the treatment of diabetic foot ulcers: a critical survey | |
Caetano et al. | Phototherapy improves healing of chronic venous ulcers | |
US6960201B2 (en) | Method for the prevention and treatment of skin and nail infections | |
CN111065363A (zh) | 医疗用敷料 | |
US7422599B2 (en) | Device for treating infants with light | |
US9555262B2 (en) | Method and apparatus for non-thermal nail, foot, and hand fungus treatment | |
EP2361116B1 (en) | Irradiation apparatus | |
IL119683A (en) | Method and device for light irradiation into tissue | |
KR101598665B1 (ko) | 피부개선 및 발모용 광 요법 장치 | |
Suan et al. | Light-based therapy on wound healing: a review | |
US11358002B2 (en) | Method and apparatus for non-thermal nail, foot, and hand fungus treatment | |
WO2007123859A2 (en) | Method and device to inactivate and kill cells and organisms that are undesirable | |
US20230045570A1 (en) | Light radiation device for medical treatment | |
Bradley | Wounds | |
CN108543231B (zh) | 一种可降解的多光谱发光植入物 | |
OA20368A (en) | Light emission device | |
RU2556608C2 (ru) | Способ неинвазивной полихроматической световой импульсной терапии | |
WO2014177837A1 (en) | Photodynamic therapy | |
Merigo et al. | Case Report Auto-Administered Photobiomodulation on Diabetic Leg Ulcers Treatment: A New Way to Manage It? | |
Karaim | Light that can cure you | |
Irvine | BIOPHYSICAL AGENTS IN WOUND CARE | |
Islam et al. | Low-Level Laser Therapy (LLLT) on Soft Tissue Healing: A Case Report with Literature Review |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230317 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230317 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20231117 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231121 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240219 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240312 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240410 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7472162 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |